OHHMED
NEWS & EVENTS

 

Ohh-Med Medical participated in Europe's most important conference on sexual medicine. Ohh-Med CEO, Daniel Lischinsky, had the opportunity to meet some of the world's leading andrologists and urologists, who were impressed and excited to see developments.

 

University of California Irvine Dept of Urology, together with Ohh-Med Medical Ltd, a biotech startup, announced the launch of the first IRB-approved clinical study to determine the efficacy of the company’s Vertica device for the treatment of Erectile Dysfunction (ED).

​

The study will be led by Dr Faysal Yafi, MD, Medical Director of the Men’s Health Program at UC Irvine.  Dr. Yafi specializes in Andrology (men’s health), which includes focus on male infertility, sexual dysfunction, and low testosterone.

​

Read the post here.

 

Prof Cobi Reisman presented the results of the pilot study conducted, including 6-month follow up data. The packed lecture hall reflected the interest of the attending physicians, who lined up to ask questions following the lecture.

​

See the presentation here. 

 

An article in the weekend edition of The Telegraph, in both print and online versions reported the results of the pilot study which was recently published in the International Journal of Impotence Research, August, 2023. 

​

With the launch of Vertica® in the UK, this represents an important step in announcing our revolutionary treatment for ED.

​

Read the article here.

​

 

Recent posts and articles in international online media include:

​

•  @kenginar visited our booth in IFA and posted a Reel to his Instagram profile which gained 4.6M views!

• A post in the Chinese WeChat platform, under a prestigious category "Medics prescribe things" with millions of viewers. You can see the original post here.

• A leading online tech reviewer in Norway posted a detailed description and interview. See it here.

​

 

An article published in the International Journal of Impotence Research, August, 2023 presents the results of the first clinical study of the Vertica Medical Device for the treatment of Erectile Dysfunction. 

One of the key outcomes of the study was that all participants had improvement, and after three months, almost 50% of the participants returned to normal hardness. 

​

Read the article here.

 

We are excited to announce the opening of Ohh-Med UK to expand the worldwide reach of Vertica, our home-use device for treating erectile dysfunction.

 

Ohh-Med UK is a wholly owned subsidiary to sell, market, and support sales of Vertica throughout the United Kingdom. Ohh-Med UK will operate a dedicated Call centre for Customer Sales and Support to provide customers in the UK with the highest level of support.

​

Read the Press Release here.

Contact Ohh-Med UK here.

 

We are back from an amazingly successful IFA. We welcomed more than 600 visitors to our booth, who learned about the Vertica breakthrough technology for the treatment of ED.  

​

 

You can read our post about our experience at IFA here.

​

 

An article published in the International Journal of Impotence Research, August, 2023 presents the results of the first clinical study of the Vertica Medical Device for the treatment of Erectile Dysfunction. 

One of the key outcomes of the study was that all participants had improvement, and after three months, almost 50% of the participants returned to normal hardness. 

​

Read the article here.

 

Vertica received Israel Ministry of Health approval to sell directly to consumers in June 2021, and in December 2022, Vertica received the CE-MDR approval to market throughout the EU.

​

The company markets its product direct to consumers through its online shops for international customers in Europe and around the world. 

Read the press release here.

​

Visit our YouTube Channel here.

.

European Society for Sexual Medicine - ESSM annual conference held every year in Rotterdam attracts European and International urologists and sexual function professionals to discuss the latest clinical advances in sexual medicine.

This year, Ohh-Med’s Vertica®, was presented in a session as part of the main conference. Dr. Sergiu Bistritzky, from the neuro-urology unit, Rambam Medical Center, Israel, presented the results of a pilot clinical study on the treatment of erectile dysfunction using radiofrequency (RF).

Important Announcement!

Vertica has been granted the CE Mark to market and sell in Europe. The CE Mark confirms that Vertica meets the high standards of the new, stringent European Medical Devices Regulation (MDR 2017/745) and assures the safety and efficacy of our innovative device. 

​

Vertica is already successfully marketed in several countries around the world, including Germany, Spain, United Kingdom, Romania, and Israel. We are now focusing on efforts to expand into additional markets.

A recent article in the "Health & Wellness" section of the Jerusalem Post explains the benefits and the innovation behind the Vertica. Vertica has received CE Mark for sales in EU and is also approved by the Israel Ministry of Health. It is now available for purchase in Israel, through the company website. 

​

​

​

​

​

Read the article here.

The story behind setting-up the Ohh-Med start-up, and how the Vertica® medical device is going to be the next workout (for erections) for many men.

​

​

​

​

​

​

​

​

​

Read the article here.